EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer

Janice Zhao iD, Brendan J Guercio iD, Deepak Sahasrabudhe

Cancers · 04.08.2023 · 15 (15) · 3969

DOI: 10.3390/cancers15153969 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.08.2023. Verfasst von Janice Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: James P. Wilmot Cancer Institute, University of Rochester, Rochester, NY 14642, USA. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilmot Physician-Scientist Fellowship Program at the Wilmot Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer is the second most common cancer among men. Despite advances in diagnosis and management, prostate cancer led to more than 300,000 deaths globally in 2020. Chemotherapy is a cornerstone of therapy for advanced prostate cancer and can prolong survival of patients with both castration-sensitive and castration-resistant disease. Herein, we present a comprehensive review of the data supporting implementation of chemotherapy in the modern treatment of advanced prostate cancer, with special attention to the use of chemotherapy for aggressive variant prostate cancer (e.g., neuroendocrine prostate cancer) and the combination of chemotherapy with androgen signaling inhibitors. As the field of prostate cancer research continues to rapidly evolve yielding novel agents and treatment modalities, chemotherapy continues to play an essential role in prolonging the survival of patients with advanced and metastatic prostate cancer.

Schlagwörter

Stichwörter der Autor:innen

cabazitaxelcastration-resistantcastration-sensitivechemotherapydocetaxelmitoxantroneoncologyprostate cancer

Autor:innen und Institutionen

  • James P. Wilmot Cancer Institute, University of Rochester, Rochester, NY 14642, USA.

ORCID-Profile: Janice Zhao, Brendan J Guercio

Förderung

  • Wilmot Physician-Scientist Fellowship Program at the Wilmot Cancer Institute

Zitieren

APA

Zhao, J., Guercio, B. J., & Sahasrabudhe, D. (2023). Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer. Cancers, 15(15), 3969. https://doi.org/10.3390/cancers15153969

Vancouver

Zhao J, Guercio BJ, Sahasrabudhe D. Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer. Cancers. 2023;15(15):3969. doi:10.3390/cancers15153969

BibTeX
@article{Zhao2023,
  author = {Zhao, Janice and Guercio, Brendan J and Sahasrabudhe, Deepak},
  title = {Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {15},
  pages = {3969},
  doi = {10.3390/cancers15153969}
}
Kostenlos starten →